Ed Sudiru
Analyst
Barclays
Equibles does not estimate personal net worth.
About Ed Sudiru
Ed Sudiru is recorded as Analyst at Barclays. Ed Sudiru has spoken on 1 investor event across 1 company, most recently for Iovance Biotherapeutics, Inc. on March 11, 2026. The companies whose calls Ed Sudiru spoke on are classified in the Healthcare sector.
Ed Sudiru on recent calls
“It's my pleasure to have iAvance Therapeutics for our next fireside chat. With me today, I have Brian Gassman, Executive Vice President of Transitional Medicine and Research, and Sarah Pellegrino, Head of IR.”
Affiliation history
-
Barclays
Analyst
Transcript header (unverified)
Current